Optimizing use of opiates in the management of cancer pain

References

• AhmedzaiSBrooksDTransdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial GroupJ Pain Symptom Manage199713254619185430
   PubMed Web of Science ®Google Scholar
• AshbyMAMartinPJacksonKAOpioid substitution to reduce adverse effects in cancer pain managementMed J Aust1999170687110026686
   PubMed Web of Science ®Google Scholar
• BattagliaJMossSRushJHaloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double blind, emergency department studyAm J Emerg Med199715335409217519
   PubMed Web of Science ®Google Scholar
• BrueraEMacMillianKHansonJThe cognitive effects of the administration of arcotics analgesics in patients with cancer painPain19893913162812850
   PubMed Web of Science ®Google Scholar
• BrueraEMillerLMcCallionJCognitive failure in patients with terminal cancer: a prospective studyJ Pain Symptom Manage1992719251517640
   PubMed Web of Science ®Google Scholar
• BrueraEPalmerJLBosnjakSMethadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind studyJ Clin Oncol200411859214701781
   PubMedGoogle Scholar
• BrueraESweeneyCMethadone use in cancer patients with pain: a reviewJ Palliat Med200251273811839235
   PubMedGoogle Scholar
• ChernyNRipamontiCPereiraJStrategies to manage the adverse effects of oral morphine: an evidence-based reportJ Clin Oncol20011925425411331334
   PubMed Web of Science ®Google Scholar
• CleelandCSPortenoyRKRueMDoes an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology GroupAnn Oncol2005169728015821119
   PubMed Web of Science ®Google Scholar
• CurtisGBJohnsonGHClarkPRelative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain modelEur J Clin Pharmacol199955425910492054
   PubMed Web of Science ®Google Scholar
• DavisMPWalshDLagmanRControversies in pharmacotherapy of pain managementLancet Oncol2005669670416129370
   PubMed Web of Science ®Google Scholar
• De ConnoFCraceniAMartiniCHyperalgesia and myoclonus with intrathecal infusion of high-dose morphinePain19914733791784504
   PubMed Web of Science ®Google Scholar
• Du PenSLDu PenARPolissarNImplementing guidelines for cancer pain management: results of a randomized controlled clinical trialJ Clin Oncol1999173617010458255
   PubMed Web of Science ®Google Scholar
• BrueraEBelzileMFainsingerRRandomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release morphine in patients with cancer painJ Clin Oncol199816322299779695
   PubMed Web of Science ®Google Scholar
• DavisMPWalshDLagmanRRandomized clinical trial of an implantable drug delivery systemJ Clin Oncol2003212800112860958
   PubMed Web of Science ®Google Scholar
• EiseleJHGrigsbyEJDeaGClonazepam treatment of myoclonic contractions associated with hidose opioids: case reportPain19924923121376887
   PubMed Web of Science ®Google Scholar
• ElliottKMinamiNKolesnikovYThe NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to the kappa opioidsPain19945669757512709
   PubMed Web of Science ®Google Scholar
• GordonDBDahlJLMiaskowskiCAmerican pain society recommendations for improving the quality of acute and cancer pain management: American Pain Society Quality of Care Task ForceArch Intern Med200516515748016043674
   PubMed Web of Science ®Google Scholar
• HanksGWConnoFChernyNMorphine and alternative opioids in cancer pain: the EAPC recommendationsBr J Cancer2001845879311237376
   PubMed Web of Science ®Google Scholar
• HeiskanenTKalsoEControlled-release oxycodone and morphine in cancer related painPain19977337459414055
   PubMed Web of Science ®Google Scholar
• KalsoEHeiskanenTRantioMEpidural and subcutaneous morphine in the management of cancer pain: a double-blind crossover studyPain19966744398951940
   PubMed Web of Science ®Google Scholar
• KaplanRParrisWCCitronMLComparison of controlled-release and immediate-release oxycodone tablets in patients with cancer painJ Clin Oncol199816323079779696
   PubMed Web of Science ®Google Scholar
• LevyMHSamuelTAManagement of cancer painSemin Oncol2005321799315815964
   PubMed Web of Science ®Google Scholar
• MaddocksISomogyiAAbbottFAttenuation of morphine induced delirium in palliative care by substitution with infusion oxycodoneJ Pain Symptom Manage19961218298803381
   PubMed Web of Science ®Google Scholar
• MandemaJWKaikoRFOshlackBCharacterization and validation of a pharmacokinetic model for controlled-release oxycodoneBr J Clin Pharmacol199642747568971431
   PubMed Web of Science ®Google Scholar
• McNicolEStrasselsSAGoudasLNSAIDs or paracetamol, alone or combined with opioids, for cancer painCochrane Database Syst Rev20052CD00518015654708
   PubMedGoogle Scholar
• MercadanteSOpioid rotation for cancer pain: Rationale and clinical aspectsCancer19998618566610547561
   PubMed Web of Science ®Google Scholar
• MercadanteSCasuccioAAgnelloAMorphine versus methadone in the pain treatment of advanced cancer patients followed up at homeJ Clin Oncol1998163656619817288
   PubMed Web of Science ®Google Scholar
• MercadanteSCasaccioAFulfaroFSwitching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective studyJ Clin Oncol200119289890411387363
   PubMed Web of Science ®Google Scholar
• Mucci-LoRussoPBermanBSSilbersteinPTControlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain. A randomized, double-blind, parallel-group studyEur J Pain199822394915102384
   PubMed Web of Science ®Google Scholar
• ObesoJATherapy of myoclonusClin Neurosci1995325378891399
   PubMedGoogle Scholar
• PaixAColemanALeesJSubcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain managementPain19956326398628593
   PubMed Web of Science ®Google Scholar
• PasternakGWMolecular biology of opioid analgesiaJ Pain Symptom Manage200529S2915907642
   PubMed Web of Science ®Google Scholar
• QuigleyCOpioid switching to improve pain relief and drug tolerabilityCochrane Database Syst Rev20062
   Google Scholar
• RileyJRossJRRutterDNo pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patientsSupp Care Cancer2006145664
   PubMed Web of Science ®Google Scholar
• RipamontiCBrunelliCRandomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survivalJ Clin Oncol2003212801212860959
   PubMed Web of Science ®Google Scholar
• RipamontiCFagnoniECampaTIs the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations? A study of cancer patients in ItalySupp Care Cancer2006144007
   PubMed Web of Science ®Google Scholar
• RipamontiCGroffLBrunelliCSwitching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?J Clin Oncol1998163216219779694
   PubMed Web of Science ®Google Scholar
• RipamontiCZeccaEBrueraEAn update on the clinical use of methadone for cancer painPain199770109159150283
   PubMed Web of Science ®Google Scholar
• SalzmanRTRobertsMSWildJCan a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?J Pain Symptom Manage199918271910534967
   PubMed Web of Science ®Google Scholar
• SjogrenPBanningAPain, sedation and reaction time during long-term treatment of cancer patients with oral and epidural opioidsPain1989395112812854
   PubMed Web of Science ®Google Scholar
• SmithTJCoynePJStaatsPSAn implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM)Ann Oncol2005168253315817596
   PubMed Web of Science ®Google Scholar
• SmithTJStaatsPSDeerTRandomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survivalJ Clin Oncol2002194040912351602
   PubMedGoogle Scholar
• TrowbridgeRDuganWJaySJDetermining the effectiveness of a clinical-practice intervention in improving the control of pain in outpatients with cancerAcad Med1997727988009311323
   PubMed Web of Science ®Google Scholar
• VainioATigerstedtIOpioid treatment for radiating cancer pain: oral administration vs. epidural techniquesActa Anaesthesiol Scand198832179853284266
   PubMed Web of Science ®Google Scholar
• WalshTDMacDonaldNBrueraEA controlled study of sustained release morphine sulphate tablets in chronic pain from advanced cancerAm J Clin Oncol199215268721590284
   PubMed Web of Science ®Google Scholar